Home › Funds › SOL Capital Management CO › GSK

SOL Capital Management CO position in GSK

GSK PLC · Health Care

SOL Capital Management CO reported holding 10,322 shares of GSK (GSK PLC) in its Q1 2026 13F filing — a position valued at US$400K, representing 0.19% of its reported portfolio and ranking #37 among its reported holdings. SOL Capital Management CO first reported this position in Q1 2026.

Latest position (Q1 2026)10.32K sh
Reported value held$399.98K
Portfolio Weight0.19%
First reportedQ1 2026
Last changeNew
Updated2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

How SOL Capital Management CO's GSK position evolved

SOL Capital Management CO first disclosed a stake in GSK in Q1 2026 at 10,322 shares (US$400K).

Quarter by quarter

QuarterSharesValueChange
Q1 2026 10.32K $399.98K New

About GSK and 13F data

GSK (GSK PLC) is a Health Care company. 23 other funds we track also report a position in GSK — the largest reported positions include Dodge & Cox (US$2.53B), DODGE & COX (US$2.53B), PRIMECAP MANAGEMENT CO/CA/ (US$1.32B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding GSK

All GSK fund holders →

FAQ

How long has SOL Capital Management CO held GSK?

SOL Capital Management CO has disclosed GSK holdings in 1 of the last 1 reported quarters, going back to Q1 2026.

What is SOL Capital Management CO's current position in GSK?

As of Q1 2026, SOL Capital Management CO holds 10.32K shares of GSK (GSK PLC), valued at $399.98K, representing 0.19% of its reported portfolio and ranking #37.

Has SOL Capital Management CO been buying or selling GSK?

In the latest 13F filing (Q1 2026), SOL Capital Management CO newly opened its position in GSK.

Which other funds hold GSK?

Other major institutional holders of GSK include Dodge & Cox, DODGE & COX, PRIMECAP MANAGEMENT CO/CA/, among 23 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.